DENVER INVESTMENT ADVISORS LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
-115,456
(-3.4%)
New positions
91
Sold out positions
86
Turnover %
16.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DEAN FOODS CO | 54,733 | NEW |
| SUSQUEHANNA BANCSHARES INC | 25,580 | NEW |
| GEF | 25,520 | NEW |
| WGL HLDGS INC | 21,070 | NEW |
| VLY | 19,922 | NEW |
| GREENHILL & CO INC | 18,122 | 50.9% |
| BURBY | 17,143 | NEW |
| Bristow Group Inc | 16,084 | 68.4% |
| QUESTCOR PHARMACEUTICALS INC COM | 14,739 | 590.7% |
| BROWN SHOE INC NEW COM | 13,109 | 39.4% |
Top Reduces (Value $000, Stocks/ETFs)
| TIDEWATER INC COM | -27,934 | -97.9% |
| SXT | -20,160 | -100.0% |
| FULT | -18,236 | -100.0% |
| THO | -17,722 | -44.8% |
| TTC | -16,968 | -100.0% |
| TRMK | -16,217 | -100.0% |
| TXRH | -16,204 | -100.0% |
| CASH AMERICA INTERNATIONAL INC | -16,182 | -39.5% |
| CYPRESS SEMICONDUCTOR CORP /DE/ | -14,920 | -100.0% |
| CUBIST PHARMACEUTICALS INC | -12,839 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|